Sana Biotechnology, Inc.

In the quarter to June 2026, EPS grew 43.6% and free cash flow fell 5.46%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years.

2.27 0.21 −8.47%

Follow SANA

Alert me

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(152.87%)	(147.41%)	(118.70%)	(96.11%)	+8 more TTM periods Free account
ROA Full definition →	(53.41%)	(59.09%)	(53.20%)	(47.13%)
ROIC Full definition →	0.00%	(1,115.75%)	(854.59%)	(394.10%)
Return on Tangible Assets Full definition →	(294.03%)	(473.57%)	(252.09%)	(150.09%)
Free Cash Flow per Share Full definition →	(0.45)	(0.48)	(0.57)	(0.61)
Free Cash Flow Full definition →	(133.99)	(132.21)	(143.33)	(158.08)
Capital Expenditures Full definition →	(1.75)	0.34	0.49	0.27
Other line items
Cash ROIC Full definition →	(41.97%)	(58.87%)	(47.23%)	(44.84%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.62	0.55	0.59	0.68
Depreciation/Fixed assets Full definition →	0.43	0.45	0.47	0.45
Capex/Depreciation Full definition →	(0.16)	0.03	0.04	0.02
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.45)	(0.48)	(0.57)	(0.61)
Capex per Share Full definition →	(0.01)	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.00	0.00

Columns are period end dates